HBW Insight editors discuss the latest European consumer healthcare industry news. This week, Tom Gallen and David Ridley look at some predictions for the future of the UK and European CBD market. Some experts see the market in two or three years dominated by big pharma, and with many products going the OTC medicines route, while others expect CBD firms in the UK to challenge the country's food regulator, the FSA, for what they call its "muddled" approach to bringing order to the already well-established British cannabidiol food supplements market.